Jane Pritchett Henderson | CFO, Turnstone Biologics

HendersonJane Pritchett Henderson is the Senior Vice President and Chief Financial Officer of Corporate Development for Voyager Therapeutics, Inc. Ms. Henderson has more than 25 years of finance experience in the life sciences industry. Prior to joining Voyager, she served as Vice President, Business Development at ISTA Pharmaceuticals, Inc., where she managed the strategic option process that culminated in the successful acquisition of ISTA by Bausch + Lomb. She also oversaw the identification and evaluation of acquisitions and licensing opportunities and intellectual property strategy at ISTA. Previously, Ms. Henderson was Executive Vice President, Chief Financial Officer and Chief Business Officer of Panacos Pharmaceuticals and served in similar roles at Axerion Therapeutics. Prior to these corporate positions, Ms. Henderson held senior investment banking positions for close to two decades in the health care groups of HSBC Securities, CIBC World Markets, Lehman Brothers and Salomon Brothers. She has represented clients on over 95 M&A and financing deals and attained the level of Managing Director of the Health Care Groups at HSBC and CIBC. Ms. Henderson currently serves as Chair of the Audit Committee and Member of the Nominating and Governance Committee on the Board of Directors of Eleven Biotherapeutics. She also serves as Secretary/Treasurer and Chairman of the Finance Committee on the Board of The EQUUS Foundation in Westport, CT. Ms. Henderson received her B.S. degree in Psychology from Duke University.